SUVRETTA CAPITAL MANAGEMENT, LLC 13D and 13G filings for Soleno Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-11 4:55 pm Sale |
2021-12-31 | 13G | Soleno Therapeutics, Inc. SLNO |
SUVRETTA CAPITAL MANAGEMENT, LLC | 0 0.000% |
-383,880 (Position Closed) |
Filing |
| 2020-11-09 4:46 pm Purchase |
2020-10-30 | 13G | Soleno Therapeutics, Inc. SLNO |
SUVRETTA CAPITAL MANAGEMENT, LLC | 383,880 7.200% |
383,880 (New Position) |
Filing |